Eurofins Scientific Acquires Majority Stake in LifeCodexx

Eurofins Scientific Acquires Element's North American Life Sciences Testing Services Business

July 20, 2026

Healthcare Services

Eurofins Scientific agreed to acquire Element Materials Technology's North American Life Sciences Testing Services business for an enterprise value of $400 million. The business, which operates 27 laboratories and facilities and employs approximately 750 people, provides biopharmaceutical, environmental, and food testing; the acquisition closed on October 1, 2026.

Eurofins Scientific Acquires Infinity Laboratories

September 16, 2024

Healthcare Services

Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.

Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam

February 9, 2022

Healthcare Services

Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.

Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam

February 9, 2022

Healthcare Services

Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.

Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan

December 10, 2021

Healthcare Services

Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.

Eurofins Scientific Acquires bioskin GmbH

August 4, 2021

Healthcare Services

Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.